We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Screening Tool Detects Multiple Health Conditions from Single Blood Drop

By LabMedica International staff writers
Posted on 22 Jul 2024

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting system via a device known as a spectrometer. More...

When utilized on complex biofluids like blood plasma, this physico-chemical technique provides in-depth molecular insights, indicating its potential for medical diagnostics. Despite its established role in chemistry and industry, infrared spectroscopy has yet to become a standard tool in medical diagnostics. To tackle this issue, scientists have developed a diagnostic tool that employs infrared light and machine learning to identify multiple health conditions in just one measurement at the population level.

The team from the BIRD group at Ludwig Maximilian University of Munich (LMU, Munich, Germany) had previously worked on methods to measure human plasma. In their most recent study, they introduced infrared molecular fingerprinting to a naturally diverse group, analyzing blood from thousands of participants in the KORA study—a long-standing health research project based in Augsburg, Germany. Adults from this study were selected randomly for medical examinations and blood donations, giving the KORA study a new dimension and purpose. Over 5,000 blood plasma samples were assessed using Fourier transform infrared (FTIR) spectroscopy.

This approach involved analyzing the blood samples with infrared light to obtain molecular fingerprints, which were then examined using machine learning to correlate with existing medical data. The findings revealed that these fingerprints could facilitate quick health screenings. The multi-task algorithm was capable of differentiating various health states, including abnormal blood lipid levels, changes in blood pressure, and the presence of type-2 diabetes, including its precursor, pre-diabetes, which often goes unnoticed. Published in Cell Reports Medicine 2024, the research highlighted the algorithm's ability to also identify individuals who were healthy and remained so over the years. This discovery was notable because finding entirely healthy individuals in a random population is challenging due to the commonality of health variations and the natural changes that occur over time.

Traditionally, different tests are required for each condition, but this new method identifies multiple health issues simultaneously, not just one at a time. The system not only identifies healthy people but also detects complex conditions involving multiple diseases and can predict the onset of metabolic syndrome years before symptoms manifest, offering a chance for early intervention. This foundational study proposes that infrared molecular fingerprinting could become an integral part of routine health screenings, allowing for more effective detection and management of conditions, particularly metabolic disorders like diabetes and abnormal cholesterol levels.

As this technology evolves and its capabilities expand through further technological development and clinical studies, more health conditions could be added to its diagnostic range. This advancement may lead to personalized health monitoring, where individuals regularly assess their health status to identify potential problems early on. Ultimately, the integration of infrared spectroscopy with machine learning is poised to revolutionize health diagnostics, providing a new, efficient means to monitor health globally using just a drop of blood and infrared light.

Related Links:
LMU


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Varicella Zoster Virus Assay
LIAISON VZV Assay Panel (IgG HT, IgM)
New
See-Saw Rocking Shaker
SH-200D-S-L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.